
The Power of Open Innovation in Pharma
The European CEO website noted that the pharmaceutical industry has suffered a significant decline in productivity in the last 25 years. Many industry observers cited a lack of internal innovation as a contributory factor to this reduction in productivity, and encouraged large pharmaceutical companies to embrace the wider biotech and academic ecosystems.
Comments Off on The Power of Open Innovation in Pharma • Read this story »
More Articles

Open R&D Models Increase Chances for Late-Stage Success
The Virtual Press Office website reported that Deloitte has released a report showing that drugs sourced via open innovation are three times more likely to achieve late-phase clinical success versus those cultivated under an in-house, closed-model approach. The study also asserts that open innovation
Comments Off on Open R&D Models Increase Chances for Late-Stage Success • Read this story »